advertisement

Topcon

Shimazaki A 1

Showing records 1 to 1 | Display all abstracts from Shimazaki A

10148 Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug
Takagi Y; Nakajima T; Shimazaki A; Kageyama M; Matsugi T; Matsumura Y; Gabelt BT; Kaufman PL; Hara H
Experimental Eye Research 2004; 78: 767-776

Issue 6-1

Change Issue


advertisement

Oculus